Healthstream (HSTM) Price to Sales (2010 - 2026)

Healthstream (HSTM) has reported Price to Sales for 17 consecutive years, with 9.52 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 14.42% year-over-year to 9.52 in Q2 2026; TTM through Jun 2026 was 2.48, a 11.45% decrease from a year earlier, with the FY2025 full-year figure at 2.24, down 32.37% from the prior year.
• Price to Sales was 9.52 for Q2 2026 at Healthstream, up from 7.47 in the prior quarter.
• Over five years, Price to Sales peaked at 13.37 in Q1 2025 and troughed at 7.47 in Q1 2026.
• A 5-year average of 10.72 and a median of 11.02 in 2022 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales surged 30.22% in 2023 and plunged 44.09% in 2026, its largest moves.
• Over 5 years, Price to Sales stood at 11.09 in 2022, then increased by 4.62% to 11.6 in 2023, then grew by 12.35% to 13.04 in 2024, then tumbled by 34.33% to 8.56 in 2025, then rose by 11.15% to 9.52 in 2026.
• The last three Price to Sales figures came in at 9.52 (Q2 2026), 7.47 (Q1 2026), and 8.56 (Q4 2025), per Business Quant data.